653. Myeloma/Amyloidosis: Therapy, excluding Transplantation; Novel Approaches for Relapsed/Refractory Myeloma and Amyloidosis
Niels W.C.J. Van De Donk, Rakesh Popat, Jeremy Larsen, et al.
725 Part 1 Results of a Dose Finding Study of Belantamab Mafodotin (GSK2857916) in Combination with Pomalidomide (POM) and Dexamethasone (DEX) for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM) according to ASH clinically relevant abstract
Suzanne Trudel, Arleigh McCurdy, Heather J Sutherland, et al.
Christine I Chen, Nizar Bahlis, Cristina Gasparetto, et al.
Yael C Cohen, Mor Zada, Shuang-Yin Wang, et al.
Terri L. Parker, Adam Rosenthal, Vaishali Sanchorawala, et al.
Jack Khouri, Faiz Anwer, Christy J. Samaras, et al.